Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?

Kreyenbuhl J, Dixon LB, McCarthy JF, Soliman S, Ignacio RV, Valenstein M.

Schizophr Bull. 2010 Mar;36(2):428-35. doi: 10.1093/schbul/sbn106. Epub 2008 Aug 20.

2.

Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.

Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M.

Psychiatr Serv. 2007 Feb;58(2):207-12.

PMID:
17287377
3.

Wide clinic-level variation in adherence to oral diabetes medications in the VA.

Bryson CL, Au DH, Maciejewski ML, Piette JD, Fihn SD, Jackson GL, Perkins M, Wong ES, Yano EM, Liu CF.

J Gen Intern Med. 2013 May;28(5):698-705. doi: 10.1007/s11606-012-2331-y. Epub 2013 Jan 31.

4.

Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?

Long JA, Wang A, Medvedeva EL, Eisen SV, Gordon AJ, Kreyenbuhl J, Marcus SC.

Diabetes Care. 2014 Aug;37(8):2261-7. doi: 10.2337/dc13-0051. Epub 2014 May 30.

PMID:
24879839
5.

Diabetes treatment among VA patients with comorbid serious mental illness.

Krein SL, Bingham CR, McCarthy JF, Mitchinson A, Payes J, Valenstein M.

Psychiatr Serv. 2006 Jul;57(7):1016-21.

PMID:
16816287
6.
7.

Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes.

Egede LE, Gebregziabher M, Hunt KJ, Axon RN, Echols C, Gilbert GE, Mauldin PD.

Ann Pharmacother. 2011 Feb;45(2):169-78. doi: 10.1345/aph.1P442.

PMID:
21304026
8.

Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.

Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC.

Schizophr Bull. 2011 Jul;37(4):727-36. doi: 10.1093/schbul/sbp121. Epub 2009 Nov 21.

9.

Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.

Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT.

J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45.

10.

Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders.

Nelson LA, Graham MR, Lindsey CC, Rasu RS.

Psychosomatics. 2011 Jul-Aug;52(4):310-8. doi: 10.1016/j.psym.2011.03.004.

PMID:
21777713
11.

Impact of medical comorbidity on the quality of schizophrenia pharmacotherapy in a national VA sample.

Chwastiak L, Rosenheck R, Leslie D.

Med Care. 2006 Jan;44(1):55-61.

PMID:
16365613
12.

Alcohol screening scores and medication nonadherence.

Bryson CL, Au DH, Sun H, Williams EC, Kivlahan DR, Bradley KA.

Ann Intern Med. 2008 Dec 2;149(11):795-804.

PMID:
19047026
13.

Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness.

Woltmann EM, Valenstein M, Welsh DE, Lee TA, Wolschon PA, Grabowski J, Reilly PA.

Psychiatr Serv. 2007 Jun;58(6):864-7.

PMID:
17535949
14.

Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.

Yusuff KB, Obe O, Joseph BY.

Pharm World Sci. 2008 Dec;30(6):876-83. doi: 10.1007/s11096-008-9243-2. Epub 2008 Sep 11.

PMID:
18784982
15.

Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.

Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS.

Adv Ther. 2012 Aug;29(8):675-90. doi: 10.1007/s12325-012-0040-x. Epub 2012 Aug 15.

PMID:
22898791
16.

Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.

van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GE.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):983-91. doi: 10.1002/pds.1810.

PMID:
19623570
17.

Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.

Melzer AC, Uman J, Au DH.

Ann Am Thorac Soc. 2015 Jun;12(6):831-7. doi: 10.1513/AnnalsATS.201501-001OC.

18.

Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.

Lin EH, Von Korff M, Ciechanowski P, Peterson D, Ludman EJ, Rutter CM, Oliver M, Young BA, Gensichen J, McGregor M, McCulloch DK, Wagner EH, Katon WJ.

Ann Fam Med. 2012 Jan-Feb;10(1):6-14. doi: 10.1370/afm.1343.

19.

Factors related to antipsychotic oversupply among Central Texas Veterans.

Yang M, Barner JC, Worchel J.

Clin Ther. 2007 Jun;29(6):1214-25.

PMID:
17692735
20.

Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.

Ciechanowski PS, Katon WJ, Russo JE.

Arch Intern Med. 2000 Nov 27;160(21):3278-85.

PMID:
11088090

Supplemental Content

Support Center